New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
J&J/DePuy’s Trumatch
You may also be interested in...
Financings In Brief
Cancer Genetics plans initial public offering. Mitralign raises $35 million for valve repair device. More financings.
New Products In Brief
A drug-eluting stent and prostate cancer assay are among newly approved devices.
New Products In Brief
St. Jude Medical’s Ilumien